MJN Neuroserveis is a healthcare company focused on epilepsy, with particular emphasis on seizure forecasting. Its core product, mjn-SERAS, is a wearable earpiece designed to monitor brain activity and alert users to possible seizures before onset. The system combines EEG sensing, real-time signal analysis, and mobile connectivity to support earlier warning of epileptic events. MJN positions the technology as a tool to improve safety, autonomy, and day-to-day management for people with epilepsy.

The device is worn in the ear canal and records EEG signals through embedded electrodes. These signals are analyzed using machine learning models trained to detect pre-ictal patterns associated with seizure risk. When the system identifies a likely seizure, it can send alerts through the earpiece and connected smartphone applications. The platform also captures event-related data that may help clinicians better understand seizure patterns over time.

MJN’s technology is aimed at reducing the risks associated with unpredictable seizures, including falls, injuries, and loss of independence. In addition to warning functions, the system may support more informed clinical management through longitudinal brain activity data. Its work reflects a broader move toward wearable, predictive neurotechnology in epilepsy care.